Zevra Therapeutics (ZVRA) Share-based Compensation (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Share-based Compensation of $2.97 million for Q2 2026, up 20.5% from $2.46 million a year earlier but down 4.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Share-based Compensation (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Zevra Therapeutics was $13.13 million, down 16.6% year-over-year; for FY2025, it came in at $12.63 million, down 15.2% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 38.4% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Share-based Compensation was $14.91 million in FY2024 (+150.4%), $5.95 million in FY2023 (+38.7%), $4.29 million in FY2022 (+76.3%) and $2.44 million in FY2021 (-2.2%).
- Quarterly Share-based Compensation has run from a low of $620,000 in Q3 2021 to a high of $6.14 million in Q3 2024 over five years.
- On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 66.0%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2022, with growth of 374.8%; the weakest was Q3 2025, with a decline of 54.8%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $3.11 million (Q1 2026), $4.28 million (Q4 2025) and $2.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 2.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.97 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 6.14 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 945,000.00 |
| Dec 31, 2022 | 955,000.00 |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 918,000.00 |
| Dec 31, 2021 | 823,000.00 |
| Sep 30, 2021 | 620,000.00 |
API Access
Zevra Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();